MicroRNAs are poised to radically change the way we care for patients with germ cell tumors (GCTs) across all disease states, from diagnosis to managing chemorefractory disease. miR-371a-3p is a promising candidate biomarker that may precisely individualize GCT treatment paradigms.
European urology. 2019 Jun 21 [Epub]
Nirmish Singla, John T Lafin, Aditya Bagrodia
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: .